Nortriptyline hydrochlorideNortriptyline hydrochloride
MedChemExpress (MCE)
HY-B1417
894-71-3
Desmethylamitriptyline hydrochloride
Desitriptilina hydrochloride
99.98%
4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months
-20°C, 1 month (sealed storage, away from moisture)
Room temperature in continental US
may vary elsewhere.
Nortriptyline (Desmethylamitriptyline) hydrochloride, the main active metabolite of Amitriptyline, is a tricyclic antidepressant. Nortriptyline hydrochloride is a potent autophagy inhibitor and has anticancer effects.
Amitriptyline is metabolized by CYP2C19 to the active metabolite, Nortriptyline. Nortriptyline blocks the reuptake of Norepinephrine more potently than Serotonin[1]. Nortriptyline (6.25-100 μM
24-72 h) hydrochloride markedly reducs the viability of TCCSUP and mouse MBT-2 bladder cancer cells in a concentration- and time-dependent manner[3]. Nortriptyline (12.55-100 μM
24 h) hydrochloride induces cell cycle arrest and apoptosis in TCCSUP and MBT-2 cells[3]. Nortriptyline (12.55-100 μM
24 h) hydrochloride induces both intrinsic and extrinsic apoptosis in these bladder cancer cells[3].
Nortriptyline (10-20 mg/kg
ip
every day
for three weeks) hydrochloride inhibits the growth of bladder tumors in mice inoculated with MBT-2 cells[3].
| | | |
| | | | | |
[1]. Dean L. Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype. Biotechnology Information (US)
2012-2017 Mar 23. [Content Brief]
[2]. Petrosyan E, et al. Repurposing Autophagy Regulators in Brain Tumors [published online ahead of print, 2022 Feb 18]. Int J Cancer. 2022
10.1002/ijc.33965. [Content Brief]
[3]. Sheau-Yun Yuan, et al. Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo. Eur J Pharmacol. 2015 Aug 15:761:309-20. [Content Brief]